Psychiatry and Neurology, Neurology · Burlington, MA
NPI
1134337249
Since 2007
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
3
Medicare group memberships
Hospitals
4
Hospital affiliations
Lahey Clinic Inc, 41 Mall Road
Burlington, MA, 01805
Phone (781) 744-8630
Groups this clinician bills Medicare through
Medicare paid, 2024
$66K
973 services
Medicare patients, 2024
388
Average age 75
Drug cost, 2024
$295K
739 prescriptions
Company payments, 2024
$8,336
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Michal Vytopil was code 95886 (electrical nerve conductivity), 160 times for 152 patients. In total Michal Vytopil billed 973 services in 38 codes, and Medicare paid $66K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2012-12-11.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 95886 Electrical Nerve Conductivity | Facility | 160 | 152 | $37.15 | $5,944 |
| 95885 Electrical Nerve Conductivity | Facility | 133 | 97 | $14.93 | $1,986 |
| 99214 Office E&M - Established | Facility | 111 | 85 | $74.42 | $8,260 |
| 99215 Office E&M - Established | Facility | 72 | 54 | $111.87 | $8,055 |
| 95910 Electrical Nerve Conductivity | Facility | 71 | 71 | $85.49 | $6,069 |
| 99233 Hospital E&M - Subsequent | Facility | 52 | 24 | $99.31 | $5,164 |
| 95911 Electrical Nerve Conductivity | Facility | 47 | 47 | $109.66 | $5,154 |
| G2212 Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Facility | 37 | 19 | $25.76 | $953 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 37 | 29 | $13.69 | $506 |
| 99205 Office E&M - New | Facility | 29 | 29 | $139.51 | $4,046 |
| 95874 Musculoskeletal | Facility | 28 | 14 | $15.94 | $446 |
| 95909 Electrical Nerve Conductivity | Facility | 28 | 28 | $61.45 | $1,721 |
| 99223 Hospital E&M - Initial | Facility | 24 | 23 | $147.80 | $3,547 |
| 95912 Electrical Nerve Conductivity | Facility | 23 | 23 | $132.01 | $3,036 |
| 95913 Electrical Nerve Conductivity | Facility | 21 | 21 | $147.15 | $3,090 |
By year: 2022 $69K for 915 services; 2023 $62K for 868 services; 2024 $66K for 973 services.
Medicare prescription drug claims, 2024
In 2024, the drug Michal Vytopil prescribed most often to Medicare patients was Gabapentin, with 126 prescriptions and refills. In total Michal Vytopil wrote 739 Medicare prescriptions that cost $295K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Gabapentin Generic | 126 | 219 | 39 | $1,430 |
| Prednisone Generic | 52 | 105 | 13 | $316 |
| Pregabalin Generic | 49 | 89 | 16 | $1,070 |
| Pyridostigmine Bromide Generic | 48 | 109 | 15 | $4,393 |
| Donepezil Hcl Generic | 39 | 62 | Under 11 | $271 |
| Azathioprine Generic | 33 | 59 | Under 11 | $11K |
| Levetiracetam Generic | 29 | 70 | Under 11 | $1,356 |
| Duloxetine Hcl Generic | 28 | 52 | Under 11 | $1,508 |
| Carbidopa-Levodopa Carbidopa/Levodopa | 27 | 69 | Under 11 | $1,566 |
| Clonazepam Generic | 24 | 24 | Under 11 | $42.38 |
| Gamunex-C Immune Globul G/Gly/Iga Avg 46 | 24 | 24 | Under 11 | $177K |
| Mycophenolate Mofetil Generic | 21 | 57 | Under 11 | $3,701 |
| Topiramate Generic | 16 | 34 | Under 11 | $247 |
| Aimovig Autoinjector Erenumab-Aooe | 14 | 27 | Under 11 | $20K |
| Lacosamide Generic | 13 | 13 | Under 11 | $2,532 |
Brand drugs: 48 claims; generic drugs: 691 claims.
Money and other things of value reported by the companies
In 2024, drug and medical device companies paid Michal Vytopil $8,336 ($8,336 in general payments such as food, travel and fees) from 2 companies. The largest payer was Genzyme Corporation with $4,532.
| Company | Payments | Amount |
|---|---|---|
| Genzyme Corporation SNY | 3 | $4,532 |
| Grifols USA, LLC | 5 | $3,804 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.